Journal of Traditional Chinese Medicine >
Untargeted serum metabonomic reveals alleviated ovalbumin-induced asthma by Baijin Pingchuan (白金平喘) through primary bile acid biosynthesis
Received date: 2023-07-22
Accepted date: 2023-11-27
Online published: 2024-11-12
Supported by
Science and Technology Development Plan Project of Jilin Provincial: Research on the Development of Baijin Pingchuan Granules as an In-hospital Preparation for the Treatment of Pediatric Asthma (Heat-type Asthma)(20200404043YY);Traditional Chinese Medicine Science and Technology Project of Jilin Provincial: Exploring the Mechanism of Baijin Pingchuan Granules in Alleviating Airway Inflammation in Asthma based on the “Three-Stage Differentiation and Treatment” Theory of National Medical Masters(2020090)
OBJECTIVE: To investigate the effect of baijinpingchuan (白金平喘, BJPC) on the asthma rat model and identify differential metabolites and disturbed metabolic pathways.
METHODS: The rats were categorized into six groups: control, dexamethasone (DEX), ovalbumin (OVA), and low-, median-, and high-dose BJPC. The rats, except for the control group, were initially treated with OVA to develop the asthma model, which was then activated using DEX, OVA, and low-, median-, and high-dose BJPC. Enzyme-linked immunosorbent assay kit was used to detect the expression of interleukin (IL)-33, IL-25, thymic stromal lymphopoietin (TSLP), and transforming growth factor-beta 1 (TGF-β1). Hematoxylin and eosin staining were performed to observe the pathological condition of the lung. Untargeted serum metabonomic analysis was conducted to identify differential metabolites and disturbed metabolic pathways.
RESULTS: High-dose BJPC significantly inhibited the expression of IL-33, IL-25, TSLP, and TGF-β1 (P < 0.0001). Further, high-dose BJPC improved inflammatory cell infiltration, which plays a similar role in asthma as DEX. OVA-induced and BJPC-treated rats were identified through 17 differential metabolites, especially cholic acid. Furthermore, primary bile acid biosynthesis was a significantly differential pathway in the mechanism of BJPC for treating asthma.
CONCLUSIONS: BJPC plays an anti-inflammation role in asthma, which might be a promising therapy through mediating primary bile acid biosynthesis.
Key words: asthma; ovalbumin; untargeted serum metabonomic; Baijin Pingchuan
Lizhong DING , Qiang ZHANG , Yingying SUN , Yibu KONG , Yongfu SONG , Yongji WANG . Untargeted serum metabonomic reveals alleviated ovalbumin-induced asthma by Baijin Pingchuan (白金平喘) through primary bile acid biosynthesis[J]. Journal of Traditional Chinese Medicine, 2024 , 44(6) : 1187 -1193 . DOI: 10.19852/j.cnki.jtcm.2024.06.007
| 1. | Padem N, Saltoun C. Classification of asthma. Allergy Asthma Proc 2019; 40: 385-8. |
| 2. | Abdo M, Pedersen F, Kirsten AM, et al. Longitudinal impact of sputum inflammatory phenotypes on small airway dysfunction and disease outcomes in asthma. J Allergy Clin Immunol Pract 2022; 10: 1545-53.e2. |
| 3. | Castillo Vizuete JA, Sastre J, Del Cuvillo Bernal A, et al. Asthma, rhinitis, and nasal polyp multimorbidities. Arch Bronconeumol (Engl Ed) 2019; 55: 146-55. |
| 4. | Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet 2018; 391: 783-800. |
| 5. | Racanelli AC, Kikkers SA, Choi AMK, Cloonan SM. Autophagy and inflammation in chronic respiratory disease. Autophagy 2018; 14: 221-32. |
| 6. | Guilleminault L, Williams EJ, Scott HA, et al. Diet and asthma: is it time to adapt our message? Nutrients 2017; 9: 1-25. |
| 7. | Brough HA, Lanser BJ, Sindher SB, et al. Early intervention and prevention of allergic diseases. Allergy 2022; 77: 416-41. |
| 8. | Li J, Zhang F, Li J. The immunoregulatory effects of Traditional Chinese Medicine on treatment of asthma or asthmatic inflammation. Am J Chin Med 2015; 43: 1059-81. |
| 9. | Zhou BW, Liu HM, Jia XH. The role and mechanisms of Traditional Chinese Medicine for airway inflammation and remodeling in asthma: overview and progress. Front Pharmacol 2022; 13: 917256. |
| 10. | Wang J, Wu Q, Ding L, et al. Therapeutic effects and molecular mechanisms of bioactive compounds against respiratory diseases: Traditional Chinese Medicine theory and high-frequency use. Front Pharmacol 2021; 12: 734450. |
| 11. | Guo P, Furnary T, Vasiliou V, et al. Non-targeted metabolomics and associations with per- and polyfluoroalkyl substances (PFAS) exposure in humans: a scoping review. Environ Int 2022; 162: 107159. |
| 12. | Zhang X, Zhu X, Wang C, Zhang H, Cai Z. Non-targeted and targeted metabolomics approaches to diagnosing lung cancer and predicting patient prognosis. Oncotarget 2016; 7: 63437-48. |
| 13. | Fonseca JR, Lucio M, Harir M, Schmitt-Kopplin P. Mining for active molecules in probiotic supernatant by combining non-targeted metabolomics and immunoregulation testing. Metabolites 2022; 12: 25-35. |
| 14. | Larsen ST, Hansen JS, Hansen EW, Clausen PA, Nielsen GD. Airway inflammation and adjuvant effect after repeated airborne exposures to di-(2-ethylhexyl)phthalate and ovalbumin in balb/c mice. Toxicology 2007; 235: 119-29. |
| 15. | Liao W, Liu W, Yan Y, et al. Hylocereus undatus flower extract suppresses OVA-induced allergic asthma in balb/c mice by reducing airway inflammation and modulating gut microbiota. Biomed Pharmacother 2022; 153: 113476. |
| 16. | Tuo HY, Ren Y, Wang ZW, et al. Effects of vor on asthmatic balb/c mice and on immune-activity of th 17 cells. Zhong Guo Ying Yong Sheng Li Xue Za Zhi 2016; 32: 137-41. |
| 17. | Tuo HY, Ren Y, Wang ZW, Cheng XL, Wang RQ. Effects of vor on asthmatic balb/c mice and on immune-activity of th17 cells. Zhong Guo Ying Yong Sheng Li Za Zhi 2016; 32: 137. |
| 18. | Hong H, Liao S, Chen F, Yang Q, Wang DY. Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type 2 inflammation. Allergy 2020; 75: 2794-804. |
| 19. | Huo R, Tian X, Chang Q, et al. Targeted inhibition of β-catenin alleviates airway inflammation and remodeling in asthma via modulating the profibrotic and anti-inflammatory actions of transforming growth factor-β(1). Ther Adv Respir Dis 2021; 15: 1-14. |
| 20. | Huo R, Tian X, Chang Q, et al. Targeted inhibition of β-catenin alleviates airway inflammation and remodeling in asthma via modulating the profibrotic and anti-inflammatory actions of transforming growth factor-β(1). Ther Adv Respir Dis 2021; 15: 1753466620981858. |
| 21. | Uraguchi K, Matsumoto N, Mitsuhashi T, et al. Association between clinical remission of infantile-onset allergic rhinitis during the school-age period and the type of housing: a longitudinal population-based Japanese study. J Pediatr Health Care 2024; 38: 629-36. |
| 22. | Wang H. Clinical study of platinum antiasthmatic granule in the treatment of infantile asthmatic period (heat asthma) in children. Changchun: Changchun University of Chinese medicine; 2020: 1-33. |
| 23. | Wang W, Li Y, Lyu Z, et al. Bronchial allergen challenge of patients with atopic asthma triggers an alarmin (IL-33, TSLP, and IL-25) response in the airways epithelium and submucosa. J Immunol 2018; 201: 2221-31. |
| 24. | An G, Wang W, Zhang X, et al. Combined blockade of IL-25, IL-33 and TSLP mediates amplified inhibition of airway inflammation and remodelling in a murine model of asthma. Respirology 2020; 25: 603-12. |
| 25. | Huang WY, Lee SH, Oh SJ, et al. Canavalia gladiata pod extract mitigates ovalbumin-induced asthma onset in male balb/c mice via suppression of mapk. Molecules 2022; 27: 1-18. |
| 26. | Sun Z, Ji N, Ma Q, et al. Epithelial-mesenchymal transition in asthma airway remodeling is regulated by the IL-33/CD 146 axis. Front Immunol 2020; 11: 1598. |
| 27. | Borowczyk J, Shutova M, Brembilla NC, Boehncke WH. IL-25 (IL-17e) in epithelial immunology and pathophysiology. J Allergy Clin Immunol 2021; 148: 40-52. |
| 28. | Roan F, Obata-Ninomiya K, Ziegler SF. Epithelial cell-derived cytokines: more than just signaling the alarm. J Clin Invest 2019; 129: 1441-51. |
| 29. | Gauvreau GM, Sehmi R, Ambrose CS, Griffiths JM. Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma. Expert Opin Ther Targets 2020; 24: 777-92. |
| 30. | Ma Y, Huang W, Liu C, et al. Immunization against tgf-β1 reduces collagen deposition but increases sustained inflammation in a murine asthma model. Hum Vaccin Immunother 2016; 12: 1876-85. |
| 31. | Choi Y, Sim S, Lee DH, et al. Effect of tgf-β1 on eosinophils to induce cysteinyl leukotriene e4 production in aspirin-exacerbated respiratory disease. PLoS One 2021; 16: e0256237. |
| 32. | Ulambayar B, Lee SH, Yang EM, Ye YM, Park HS. Association between epithelial cytokines and clinical phenotypes of elderly asthma. Allergy Asthma Immunol Res 2019; 11: 79-89. |
| 33. | Kim DI, Song MK, Lee K. Comparison of asthma phenotypes in ova-induced mice challenged via inhaled and intranasal routes. BMC Pulm Med 2019; 19: 241. |
| 34. | Maleki SJ, Crespo JF, Cabanillas B. Anti-inflammatory effects of flavonoids. Food Chem 2019; 299: 125124. |
| 35. | Ho WE, Xu YJ, Xu F, et al. Metabolomics reveals altered metabolic pathways in experimental asthma. Am J Respir Cell Mol Biol 2013; 48: 204-11. |
| 36. | Mougey EB, Feng H, Castro M, Irvin CG, Lima JJ. Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response. Pharmacogenet Genomics 2009; 19: 129-38. |
| 37. | Cheng BF, Hou YY, Jiang M, et al. Anti-inflammatory mechanism of Qingfei Xiaoyan Wan studied with network pharmacology. Yao Xue Xue Bao 2013; 48: 686-93. |
| 38. | Kad?Ubowski R. Advantageous effect of jaundice on bronchial asthma and anti-anaphylactic properties of bile and cholic acid. Pol Tyg Lek (Wars) 1950; 5: 1561-5. |
/
| 〈 |
|
〉 |